These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1135 related articles for article (PubMed ID: 2242781)

  • 21. A mild form of xeroderma pigmentosum assigned to complementation group G and its repair heterogeneity.
    Ichihashi M; Fujiwara Y; Uehara Y; Matsumoto A
    J Invest Dermatol; 1985 Sep; 85(3):284-7. PubMed ID: 4031543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xeroderma pigmentosum variant associated with multiple cancers.
    Kuwamoto K; Miyauchi-Hashimoto H; Isei T; Horio T
    Photodermatol Photoimmunol Photomed; 1999; 15(3-4):127-32. PubMed ID: 10404723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Report of three sisters with XP-E, a rare xeroderma pigmentosum complementation group.
    Fischer E; Schnyder UW; Jung EG
    Photodermatol; 1984 Oct; 1(5):232-6. PubMed ID: 6531300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basosquamous carcinoma and melanoma collision tumor in a child with xeroderma pigmentosum.
    Bostanci S; Akay BN; Kirmizi A; Okcu Heper A; Farabi B
    Pediatr Dermatol; 2020 Mar; 37(2):390-392. PubMed ID: 31957124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xeroderma pigmentosum variant associated with multiple skin cancers and a lung cancer.
    Mamada A; Miura K; Tsunoda K; Hirose I; Furuya M; Kondo S
    Dermatology; 1992; 184(3):177-81. PubMed ID: 1392108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium butyrate stimulates cellular recovery from UV damage in xeroderma pigmentosum cells belonging to complementation group F.
    Nishigori C; Takebe H
    Jpn J Cancer Res; 1987 Sep; 78(9):932-6. PubMed ID: 3117749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 10-year follow-up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole-genome sequencing.
    Ono R; Masaki T; Mayca Pozo F; Nakazawa Y; Swagemakers SM; Nakano E; Sakai W; Takeuchi S; Kanda F; Ogi T; van der Spek PJ; Sugasawa K; Nishigori C
    Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):174-80. PubMed ID: 26993158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of xeroderma pigmentosum (XP); variability and stability within and between the complementation groups C, D, E, I and variants.
    Jung EG; Bohnert E; Fischer E
    Photodermatol; 1986 Jun; 3(3):125-32. PubMed ID: 3748852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xeroderma pigmentosum and squamous cell carcinoma of the tongue. Identification of two black patients as members of complementation group C.
    Wade MH; Plotnick H
    J Am Acad Dermatol; 1985 Mar; 12(3):515-21. PubMed ID: 3989010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells.
    Takebe H; Nishigori C; Tatsumi K
    J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assignment of a Chinese xeroderma pigmentosum patient from Taiwan to complementation group C.
    Wang Y; Kobayashi K; Chang HR; Zeng Y; Ishizaki K; Dai H; Kuan YZ; Ikenaga M
    J Radiat Res; 1991 Jun; 32(2):181-90. PubMed ID: 1941768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic mosaicism for DNA repair capacity in fibroblasts derived from a group A xeroderma pigmentosum patient.
    Chang HR; Ishizaki K; Sasaki MS; Toguchida J; Kato M; Nakamura Y; Kawamura S; Moriguchi T; Ikenaga M
    J Invest Dermatol; 1989 Oct; 93(4):460-5. PubMed ID: 2570806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precursor lesion of malignant melanoma in xeroderma pigmentosum: reflections about solar lentigo as the precursor.
    Hedblad MA; Borglund E
    J Am Acad Dermatol; 1995 Apr; 32(4):680-2. PubMed ID: 7755744
    [No Abstract]   [Full Text] [Related]  

  • 36. Establishment and characterization of a melanoma cell line from a xeroderma pigmentosum patient: activation of N-ras at a potential pyrimidine dimer site.
    Keijzer W; Mulder MP; Langeveld JC; Smit EM; Bos JL; Bootsma D; Hoeijmakers JH
    Cancer Res; 1989 Mar; 49(5):1229-35. PubMed ID: 2645048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA repair characteristics and skin cancers of xeroderma pigmentosum patients in Japan.
    Takebe H; Miki Y; Kozuka T; Furuyama JI; Tanaka K
    Cancer Res; 1977 Feb; 37(2):490-5. PubMed ID: 832273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of xeroderma pigmentosum complementation group C with diverse clinical features.
    Masaki T; Nakano E; Okamura K; Ono R; Sugasawa K; Lee MH; Suzuki T; Nishigori C
    Br J Dermatol; 2018 Jun; 178(6):1451-1452. PubMed ID: 29330851
    [No Abstract]   [Full Text] [Related]  

  • 39. Xeroderma pigmentosum complementation group G--report of two cases.
    Norris PG; Hawk JL; Avery JA; Giannelli F
    Br J Dermatol; 1987 Jun; 116(6):861-6. PubMed ID: 3620347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
    Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
    Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.